SCHEMBL5113579

SCHEMBL5113579

CC1(C)CC(=NO)c2ccc(-c3ccc(Cl)cc3)cc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 7/20 0.49
HTT P42858 2/20 0.41
PDK2 Q15119 1/20 0.40
TDP2 O95551 2/20 0.40
ALOX5 P09917 1/20 0.36
JAK2 O60674 1/20 0.35
NTRK1 P04629 1/20 0.35
MET P08581 1/20 0.35
FGFR1 P11362 1/20 0.35
PRKACA P17612 1/20 0.35
KDR P35968 1/20 0.35
MAP2K2 P36507 1/20 0.35
FLT3 P36888 1/20 0.35
GSK3B P49841 1/20 0.35
MAP2K1 Q02750 1/20 0.35
MST1R Q04912 1/20 0.35
NTRK3 Q16288 1/20 0.35
NTRK2 Q16620 1/20 0.35
CAMK1D Q8IU85 1/20 0.35
ESR1 P03372 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5113573 1.00 PGR (0.49) PGRHTTPDK2TDP2ALOX5
SCHEMBL5123320 0.91 PGR (0.50) PGRHTTPDK2TDP2RXRA
SCHEMBL5123326 0.91 PGR (0.50) PGRHTTPDK2TDP2RXRA
SCHEMBL5122796 0.89 PGR (0.65) PGRPDK2TDP2ALOX5ESR2
SCHEMBL5122784 0.89 PGR (0.65) PGRPDK2TDP2ALOX5ESR2
SCHEMBL5117651 0.89 PGR (0.45) PGRHTTCNR1CNR2
SCHEMBL5117659 0.89 PGR (0.45) PGRHTTCNR1CNR2
SCHEMBL5124405 0.88 PGR (0.63) PGRHTTTDP2
SCHEMBL5124400 0.88 PGR (0.63) PGRHTTTDP2
SCHEMBL5118804 0.88 PGR (0.46) PGRHTTPDK2TDP2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414142-B2 5-aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators WYETH (US) 2008-08-19 US disclosed
US-20070066637-A1 5-Aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators WYETH (US) 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066637-A1 5-Aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators CYP19A1, PGR, GNRHR PGR 2/4885HTT 4288/4885PDK2 1808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.